2023
Application of the International System for Reporting Serous Fluid Cytopathology to pericardial fluid: Root cause analysis of indeterminate diagnoses, cytohistological correlation, and assessment of malignancy risk
Wang M, Sun T, Jiao J, Wang H. Application of the International System for Reporting Serous Fluid Cytopathology to pericardial fluid: Root cause analysis of indeterminate diagnoses, cytohistological correlation, and assessment of malignancy risk. Cancer Cytopathology 2023, 131: 433-441. PMID: 36973963, DOI: 10.1002/cncy.22696.Peer-Reviewed Original Research
2022
Risk of malignancy assessment of the International System for Reporting Serous Fluid Cytopathology: Experience in a community hospital setting and comparison with other studies
Sun T, Wang M, Wang H. Risk of malignancy assessment of the International System for Reporting Serous Fluid Cytopathology: Experience in a community hospital setting and comparison with other studies. Cancer Cytopathology 2022, 130: 964-973. PMID: 35994357, DOI: 10.1002/cncy.22638.Peer-Reviewed Original ResearchMeSH KeywordsExudates and TransudatesHospitals, CommunityHumansNeoplasmsPleural EffusionRetrospective StudiesConceptsCommunity hospital settingPeritoneal effusionPleural effusionSerous Fluid CytopathologyHospital settingInternal review board approvalReview board approvalPleural fluid specimensUndetermined significanceCommunity hospitalEffusion specimensBoard approvalFluid specimensSerous fluidEffusionOverall ROMMalignancyMalignancy assessmentAUSROM analysisNotable heterogeneityAssociated riskReporting terminologyCytopathologyRisk